ABT737 is the first-generation BH3 mimetic with a high affinity for antiapoptotic BCL-2, BCL-XL, and BCL-W proteins and can effectively kill lymphoma and small cell lung cancer (SCLC) cells [3]. This evidence concerns the gene BCL2 and small cell lung carcinoma.